
@KeeleUniversity @SoM_Research @NIHRresearch #fracture prevention #bonehealth #SharedDecisionMaking for all @NIHRcommunity @RoyalOsteoSoc @HaywoodFoundtn
- Tweets96
- Following95
- Followers120
- Likes165

ALT Background and study aims The iFraP study team have developed a web-based visual tool called a ‘decision-support tool’ to support Fracture Liaison Service (FLS) healthcare professionals to know when to suggest treatments and aid conversations with patients about risk and to make decisions, for instance about starting osteoporosis medicines. The team have also developed training for healthcare professionals to help them use the tool and to ensure that the information they are giving is understandable, that they address patient concerns, and that they give clear, consistent information during the appointment. The decision-support tool and training package together are called the ‘iFraP intervention’. The iFraP study will look at whether the iFraP intervention makes decision-making about osteoporosis medicines easier, and whether it is cost-effective, acceptable and practical to deliver.

















